Second Pharma and Handewei Pharmaceutical fined for monopoly on API price
Zhejiang Second Pharma Co., Ltd. (Second Pharma) and Tianjin Handewei Pharmaceutical Co., Ltd. (Handewei Pharmaceutical) were fined USD66,107.70 (RMB443,900) in total for their unfairly high prices of isoniazide active pharmaceutical ingredient (API...
Vitamins China E-News 201708